Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting - Scorecard - MDSpire
Advertisement
Orchestrating the pre-metastatic niche: roles of stromal mediators and immune cells in metastatic progression and therapeutic targeting
Clinical Scorecard: Coordinating the Pre-Metastatic Niche: The Impact of Immune Cells and Stromal Factors on Metastatic Development and Treatment Strategies
At a Glance
Category
Detail
Condition
Tumor Metastasis
Key Mechanisms
Formation of the pre-metastatic niche (PMN) through immune suppression and extracellular matrix (ECM) remodeling.
Target Population
Patients with malignant cancers.
Care Setting
Oncology and cancer treatment facilities.
Key Highlights
PMN formation is crucial for tumor cell seeding and early metastatic outgrowth.
Immune cells and stromal components play coordinated roles in PMN establishment.
Therapeutic strategies targeting PMN mediators show potential for anti-metastatic intervention.
Guideline-Based Recommendations
Diagnosis
Early detection of metastasis through understanding PMN mechanisms.
Management
Targeting immune suppression and ECM remodeling in therapeutic strategies.
Monitoring & Follow-up
Assessing the dynamics of PMN and MN transitions in patients.
Risks
Increased metastatic potential due to PMN establishment.
Patient & Prescribing Data
Patients with various types of malignant tumors.
Focus on interventions that disrupt PMN formation and enhance immune response.
Clinical Best Practices
Integrate knowledge of PMN dynamics into cancer treatment protocols.
Utilize biomarkers related to immune and stromal interactions for patient monitoring.
